International Journal of Women's Health

Current Challenges and Future Directions in Gynecologic Cancer: Epidemiology, Prevention and Emerging Therapies

Gynecologic cancers, including malignancies of the uterine cervix, ovary, endometrium, vulva, and vagina, present a significant and growing health burden globally. These cancers are predisposed by a complex interplay of genetic, environmental, and lifestyle factors, with incidence and outcomes varying significantly by geographic region, access to healthcare, and socioeconomic status. Despite advances in early detection, surgical techniques, radiation therapy, and systemic treatments, gynecologic cancers remain a leading cause of cancer-related morbidity and mortality in women. As populations age and new risk factors and disease patterns emerge, we urgently need to grow our understanding of gynecologic cancer epidemiology, refine preventive strategies, and develop more effective therapies with fewer comorbidities.

This Article Collection aims to bring together cutting-edge research and expert perspectives to address the current challenges and future directions in gynecologic oncology, with a focus on epidemiology, prevention, and emerging therapies. We hope to promote an integrative approach to gynecologic cancer care that crosses prevention, diagnosis, treatment, and survivorship by highlighting the latest advances in basic, translational, and clinical research.

We envision this Collection to aid as a platform for assorted contributions, including global epidemiologic studies, novel preventive and screening strategies, innovative therapeutic approaches such as immunotherapy and targeted therapy, and insights into disparities in gynecologic cancer care. Additionally, this Collection aims to address critical topics such as the impact of genetic and molecular biomarkers on personalized treatment and the potential of multidisciplinary collaborations to enhance patient outcomes and quality of life.

Subtopics

• Global epidemiology and disparities in gynecologic cancer
• Advances in preventive and screening strategies
• Novel therapeutics: immunotherapy, targeted therapy, and beyond
• Genetic and molecular biomarkers in gynecologic cancer
• Multidisciplinary approaches to gynecologic cancer care

Preferred article types include original research, systematic reviews, meta-analyses, policy and practice reports and case reports, all in line with the journal’s accepted article types.

Keywords

Gynecologic oncology; Cancer epidemiology; Prevention strategies; Targeted therapy; Immunotherapy in gynecologic cancers; Biomarkers; Disparities in cancer care; Multidisciplinary cancer treatment

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts.  

Please review the journal scope and author submission instructions prior to submitting a manuscript.  

The deadline for submitting manuscripts is August 30th, 2025. 

Please submit your manuscript on our website, quoting the promo code QOQGD for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Menghan Li at menghan.li@taylorandfrancis.com  with any queries and discount codes regarding this Article Collection.